Edition:
United Kingdom

JCR Pharmaceuticals Co Ltd (4552.T)

4552.T on Tokyo Stock Exchange

4,600JPY
22 Nov 2017
Change (% chg)

-- (--)
Prev Close
¥4,600
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
151,308
52-wk High
¥4,800
52-wk Low
¥2,133

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -- March 23 Nov 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 2
(2) OUTPERFORM 2 2 1 0
(3) HOLD 3 3 2 2
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.14 2.14 2.00 2.00

Consensus Estimates Analysis

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-18 1 5,600.00 5,600.00 5,600.00 --
Year Ending Mar-17 5 18,530.00 19,000.00 18,060.00 --
Year Ending Mar-18 7 20,233.10 20,662.00 19,500.00 20,057.80
Year Ending Mar-19 7 21,659.90 22,600.00 20,700.00 21,365.00
Earnings (per share)
Year Ending Mar-17 6 60.83 66.50 53.80 --
Year Ending Mar-18 7 77.68 91.00 62.40 74.09
Year Ending Mar-19 7 88.28 126.90 67.50 92.98
LT Growth Rate (%) 1 23.45 23.45 23.45 12.63

Historical Surprises

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 5,300.00 5,801.00 501.00 9.45
Quarter Ending Mar-15 4,311.00 4,539.00 228.00 5.29
Quarter Ending Dec-14 3,950.00 4,160.95 210.95 5.34
Quarter Ending Sep-14 4,410.00 4,343.89 66.11 1.50
Quarter Ending Jun-14 3,690.00 3,811.49 121.49 3.29

Consensus Estimates Trend

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-18 5,600.00 5,600.00 5,600.00 -- --
Year Ending Mar-17 18,530.00 -- -- -- --
Year Ending Mar-18 20,233.10 20,161.70 19,924.70 19,872.60 20,057.80
Year Ending Mar-19 21,659.90 21,574.10 21,589.90 21,691.80 21,365.00

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-18 0 0 0 0
Year Ending Mar-17 -- -- -- --
Year Ending Mar-18 1 0 4 0
Year Ending Mar-19 1 0 3 1
Earnings